Zakrowski Donald A 4

What Happened

• Donald A. Zakrowski, Senior Vice President, Finance & Chief Accounting Officer at Eli Lilly (LLY), was granted equity awards on 2026-02-09. He acquired 583.784 restricted stock units (RSUs) valued at $1,044.67 each (aggregate value $609,862) and 199.472 derivative RSUs reported at $0.00 (contingent awards).

Key Details

• Transaction date: 2026-02-09; Form 4 filed: 2026-02-11 (filed within the normal 2-business-day window).
• Awarded: 583.784 RSUs @ $1,044.67 (aggregate $609,862) and 199.472 RSUs reported as derivative awards @ $0.00.
• Shares owned after transaction: Not disclosed in the provided data.
• Footnote: Each RSU is a contingent right to receive one share of Eli Lilly common stock (i.e., the units convert to shares if and when vesting conditions are met).
• Transaction code: A = Award/Grant (an acquisition via compensation, not an open-market purchase).

Context

• These were compensation grants (awards), not open-market purchases or sales. The RSUs convey a future right to receive shares subject to vesting; the $0.00 on the derivative line reflects that no cash changed hands and the units have contingent value pending vesting. Such grants are routine executive compensation and are not, by themselves, a direct market signal.